George M Hoffman

Dr. George M Hoffman

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2005 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RWRodney E. Jr. Willoughby
Rodney E. Jr. Willoughby
KTKelly S. Tieves
Kelly S. Tieves
GHGeorge M Hoffman
George M Hoffman
NGNancy S. Ghanayem
Nancy S. Ghanayem
CACatherine M. Amlie-Lefond
Catherine M. Amlie-Lefond
CRCharles E. Rupprecht
Charles E. Rupprecht
We report the survival of a 15-year-old girl in whom clinical rabies developed one month after she was bitten by a bat. Treatment included induction of coma while a native immune response matured; rabies vaccine was not administered. The patient was treated with ketamine, midazolam, ribavirin, and amantadine. Probable drug-related toxic effects included hemolysis, pancreatitis, acidosis, and hepatotoxicity. Lumbar puncture after eight days showed an increased level of rabies antibody, and sedation was tapered. Paresis and sensory denervation then resolved. The patient was removed from isolation after 31 days and discharged to her home after 76 days. At nearly five months after her initial hospitalization, she was alert and communicative, but with choreoathetosis, dysarthria, and an unsteady gait.

1 November 2003 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
NGN.S Ghanayem
N.S Ghanayem
GHGeorge M Hoffman
George M Hoffman
KMK.A Mussatto
K.A Mussatto
JCJ.R Cava
J.R Cava
PFP.C Frommelt
P.C Frommelt
JTJ.S Tweddell
J.S Tweddell

24 September 2002 in Circulation
Verified
Journal Article
Closed access
PDF file
JTJames S. Tweddell
James S. Tweddell
GHGeorge M Hoffman
George M Hoffman
KMKathleen A. Mussatto
Kathleen A. Mussatto
RFRaymond T. Fedderly
Raymond T. Fedderly
SBStuart Berger
Stuart Berger
SLS. Bert Litwin
S. Bert Litwin
Background Outcome of stage 1 palliation (S1P) for hypoplastic left heart syndrome (HLHS) has improved coincident with application of treatment strategies including continuous superior vena cava oximetry (SvO 2 ), phenoxybenzamine (POB), strategies to minimize the duration of deep hypothermic circulatory arrest (DHCA) and efforts to ameliorate the inflammatory response to cardiopulmonary bypass (CPB) using aprotinin and modified ultrafiltration. Methods and Results Analysis of a consecutive series of 115 patients undergoing S1P was done to identify the risk factors for mortality and the impact of new treatment strategies. For the current era, July 1996 to October 2001, hospital survival was 93% (75/81) compared with 53% (18/34) for the time period, January 1992 to June 1996, P <0.001. Survival to stage 2 palliation (S2P) was also significantly improved in the current era, 81% (66/81) versus 44% (15/34), P <0.01. Anti-inflammatory treatment strategies demonstrated improved survival by univariate analysis ( P <0.001). Multivariate analysis identified continuous SvO 2 monitoring as a factor favoring S1P survival ( P =0.02) and use of POB as a factor favoring survival to S2P ( P =0.003). In the current era shorter duration of DHCA was associated with improved survival to S2P ( P =0.02). Conclusions–Improved survival following S1P can be achieved with strategies that allow for early identification of decreased systemic output and the use of afterload reduction to stabilize systemic vascular resistance and therefore the pulmonary to systemic flow ratio. Strategies to ameliorate the inflammatory response to CPB may decrease the degree and duration of postoperative support. Strategies to minimize duration of DHCA may improve intermediate survival and merit additional studies.

1 February 2002 in Pediatrics
Verified
Journal Article
Closed access
GHGeorge M Hoffman
George M Hoffman
RNRhonda Nowakowski
Rhonda Nowakowski
TTTodd J. Troshynski
Todd J. Troshynski
RBRichard J. Berens
Richard J. Berens
SWSteven J. Weisman
Steven J. Weisman
Objective. Guidelines for risk reduction during procedural sedation from the American Academy of Pediatrics (AAP) and the American Society of Anesthesiologists (ASA) rely on expert opinion and consensus. In this article, we tested the hypothesis that application of an AAP/ASA-structured model would reduce the risk of sedation-related adverse events.Methods. Prospectively coded sedation records were abstracted by a hospital quality improvement specialist with practical and administrative experience in pediatric sedation. Process variables included notation of nulla per os (NPO) status, performance of a guided risk assessment, assignment of ASA physical status score, obtaining informed consent, generation of a sedation plan, and assessment of sedation level using a quantitative scoring system. Content variables included adherence to AAP NPO guidelines, ASA class, target sedation level, actual sedation level, age, procedure, and drugs used. Complication risk was assessed by logistic regression and Mantel-Haenszel odds ratios (OR).Results. Complications were identified in 40 of 960 records (4.2%). The complication rate was 34 of 895 (3.8%) with planned conscious sedation and 6 of 65 (9.2%) with planned deep sedation ([DS]; OR: 2.6). Complications were reduced by performance of structured risk assessment (OR: 0.10), adherence to all process guidelines (OR: 0), and avoiding actual DS (OR: 0.4). The only drug associated with higher risk was chloral hydrate (OR: 2.1). Failure to adhere to NPO guidelines did not increase risk in this assessment; however, the adverse event rate was 0 if all process guidelines were followed.Conclusions. Presedation assessment reduces complications of DS. Repeated assessment of sedation score reduces the risk of inadvertent DS. The data provide direct evidence that AAP/ASA guidelines can reduce the risk of pediatric procedural sedation.

1 March 2014 in Pediatrics
Verified
Journal Article
Closed access
KMKathleen A. Mussatto
Kathleen A. Mussatto
RHRaymond G. Hoffmann
Raymond G. Hoffmann
GHGeorge M Hoffman
George M Hoffman
JTJames S. Tweddell
James S. Tweddell
LBLaurel Bear
Laurel Bear
CBCheryl Brosig
Cheryl Brosig
BACKGROUND AND OBJECTIVE: Children with congenital heart disease (CHD) are at risk for developmental delay (DD). Changes in cognitive, language, and motor skills in early childhood have not been described. We report the results of a structured approach using longitudinal testing to identify problems and ensure early intervention in accordance with published guidelines. METHODS: Bayley Scales of Infant Development, Third Edition, were used to assess cognitive, language, and motor skills in 99 children with CHD. Subjects were evaluated 3 to 6 times in the first 3 years of life. DD was defined as scores >1 SD below the population mean. RESULTS: Cardiac anatomy was single ventricle (1V) in 34 subjects and 2 ventricles (2V) in 65. Medical comorbidities were present in 21% and genetic syndromes in 19%. Most subjects (75%) had DD in ≥1 area at ≥1 assessments. Subjects with 1V anatomy had equivalent outcomes to those with 2V. Cognitive and language scores declined in subjects with genetic syndromes but were stable and within the average range for subjects with 1V and 2V. Motor scores improved for subjects with 1V and 2V but remained low for those with genetic syndromes. In addition to age, need for supplemental tube feeding, longer cardiopulmonary bypass time, and shorter time since last hospitalization were significant predictors of developmental outcomes. CONCLUSIONS: DDs in young children with CHD are both common and dynamic. Providers should encourage longitudinal surveillance for children with CHD because exposure to risk and prevalence of DD change over time.

1 August 1999 in Critical Care Medicine
Verified
Journal Article
Closed access
NBNapa Balasubramanyan
Napa Balasubramanyan
PHPeter L. Havens
Peter L. Havens
GHGeorge M Hoffman
George M Hoffman
This study was undertaken to compare three methods for the identification of unmeasured anions in pediatric patients with critical illness. We compared the base excess (BE) and anion gap (AG) methods with the less commonly used Fencl-Stewart strong ion method of calculating BE caused by unmeasured anions (BEua). We measured the relationship of unmeasured anions identified by the three methods to serum lactate concentrations and to mortality. Retrospective cohort study. Tertiary care pediatric intensive care unit in an academic pediatric hospital. The study population included 255 patients in the pediatric intensive care unit who had simultaneous measurements of arterial blood gases, electrolytes, and albumin during the period of July 1995 to December 1996. Sixty-six of the 255 patients had a simultaneous measurement of serum lactate. The BEua was calculated using the Fencl-Stewart method. The AG was defined as (sodium plus potassium) - (chloride plus total carbon dioxide). BE was calculated from the standard bicarbonate, which is derived from the Henderson-Hasselbalch Equation andreported on the blood gas analysis. A BE or BEua value of or=to17 mEq/L was defined as a clinically significant presence of unmeasured anions. A lactate level of >or=to45 mg/dL was defined as being abnormally elevated for this study. The presence of unmeasured anions identified by significantly abnormal BEua was poorly identified by BE or AG. Of the 255 patients included in the study, 67 (26%) had a different interpretation of acid base balance when the Fencl method was used compared with when BE and AG were used. Plasma lactate concentration correlated better with BEua (r2 = .55; p = .0001) than with AG (r2 = .41; p = .0005) or BE (r2 = .27; p = .025). Mortality was more strongly related to BEua or=to45 mg/dL (relative risk of death = 2.35; p = .04). In logistic regression analysis, mortality was more strongly associated with BEua (area under the receiver operating characteristic curve = 0.79; p = .0002) than lactate (receiver operating characteristic curve area = 0.63; p = .05), BE (receiver operating characteristic curve area = 0.53; p = .32), or AG (receiver operating characteristic curve area = 0.64; p = .08) in this patient sample. Critically ill patients with normal BE and normal AG frequently have elevated unmeasured anions detectable by BEua. The Fencl-Stewart method is better than BE and similar to AG in identifying patients with high lactate levels. Elevated unmeasured anions identified by the Fencl-Stewart method were more strongly associated with mortality than with BE, AG, or lactate in this patient sample. (Crit Care Med 1999; 27:1577-1581)